Your browser doesn't support javascript.
loading
The serum levels of angiopoietin-like protein 3 and 4 in type 2 diabetic patients with and without metabolic syndrome compared to the control group.
Hezarkhani, Sharabeh; Hajighaderi, Aytekin; Hosseinzadeh, Sara; Behnampour, Naser; Veghari, Gholamreza; Fathabadi, Farshid; Hesari, Zahra; Joshaghani, Hamid Reza.
Affiliation
  • Hezarkhani S; Metabolic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Hajighaderi A; Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Hosseinzadeh S; Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Behnampour N; Department of Biostatistics, Faculty of Health, Golestan University of Medical Sciences, Gorgan, Iran.
  • Veghari G; Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Fathabadi F; Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Hesari Z; Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
  • Joshaghani HR; Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Endocrinol Diabetes Metab ; 7(1): e466, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38140923
ABSTRACT

INTRODUCTION:

ANGPTLs (Angiopoietin-like proteins) 3 and 4 play an important role in the development of type 2 diabetes. These glycoproteins affect the modulation of glucose and lipid metabolism. They inhibit lipoprotein lipase (LPL) activity and provoke lipolysis. This study was aimed to investigate the protein levels of ANGPTL3 and 4 in the serum of type 2 diabetic patients with metabolic syndrome in comparison to the type 2 diabetic patients without metabolic syndrome and the control group.

METHODS:

Three groups of individuals were included in this study; Group I 47 patients with type 2 diabetes and metabolic syndrome; Group II 25 patients with type 2 diabetes without metabolic syndrome; Group III 40 non-diabetic healthy people without metabolic syndrome as a control group. After collection of 5 mL fasting blood samples, serum concentrations of fasting blood sugar (FBS), cholesterol (Chol), triglyceride (TG), HDL-C (High-density lipoprotein-Cholesterol) and LDL-C (Low-density lipoprotein-Cholesterol) were measured by the enzymatic method; blood pressure (BP), height and weight with stadiometers; and ANGPTL3 and 4 by the enzyme-linked immunosorbent assay (ELISA).

RESULTS:

The serum levels of ANGPTL3 was significantly different among our three groups (p = .000). In patients with type 2 diabetes and metabolic syndrome (Group I), ANGPTL3 and 4 levels were lower than the control group. The serum levels of the parameters evaluated in this study (except HDL-C) was lower in the group II in comparison with the group I, and this difference was significant for TG, Chol, BP and BMI between these two groups. Also, our results revealed that there was a negative correlation between FBS, TG, Chol, LDL-C and BMI with ANGPTL3 and 4. While, there was a significant positive correlation between ANGPTL4 and ANGPTL3.

CONCLUSION:

Altogether, our findings suggest that the decreased levels of ANGPTL3 and 4 may be a causative factor for type 2 diabetes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Endocrinol Diabetes Metab Year: 2024 Document type: Article Affiliation country: Iran

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metabolic Syndrome / Diabetes Mellitus, Type 2 Limits: Humans Language: En Journal: Endocrinol Diabetes Metab Year: 2024 Document type: Article Affiliation country: Iran